ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Talc Victims to Johnson & Johnson: There’s No Escaping Science Linking Talc with Ovarian Cancer and Mesothelioma

More than 40 studies demonstrate that genital use of talc increases cancer risk

In light of a recent lawsuit against a testifying scientific expert by lawyers for Johnson & Johnson, ovarian cancer victims are urging members of the public, government regulators, and members of Congress to condemn the company’s conduct and reinforce the science that clearly establishes a link between J&J’s talc products and cancer:

  • Analysis of J&J’s talcum powder products has consistently revealed asbestos, fibrous talc, and other carcinogens.
  • Studies in women consistently demonstrate that genital use of talcum powder increases the risk of and can cause ovarian cancer.
  • Credible scientific studies demonstrate that talcum powder causes inflammation, and that chronic inflammation causes ovarian cancer.
  • J&J has known of the dangers of talcum powder for decades. Since the 1980s, more than 40 published epidemiologic studies have examined the link between genital talc use by women and ovarian cancer and have documented significant links between the two.

“There is no denying that talc causes cancer,” says attorney Leigh O’Dell of the Beasley Allen Law Firm, who serves as Co-Lead Counsel for consolidated multidistrict litigation (MDL) in New Jersey. “A federal judge put the science and J&J’s denials on trial over eight days and ruled that the science exceeded the high standard required to allow it to be presented in court. State trial and appellate courts around the country that have considered the question have reached the same conclusion.”

Unbiased consumers, serving on juries, have voted for billions of dollars in compensation and damages. In June 2021 Johnson & Johnson paid 22 cancer victims and their families more than $213 million each. On appeal, the court called the company’s conduct “reprehensible.” In October 2021, the company, valued at nearly a half-trillion dollars, sought to protect profits by transferring its legal liability to a subsidiary and placing it into bankruptcy. The “Texas two-step” tactic was rejected by the U.S. Court of Appeals for the Third Circuit leading to a recent second bankruptcy filing by the same subsidiary.

“J&J is exploiting and abusing the law in an attempt to distract attention from its victims,” says attorney Andy Birchfield of Beasley Allen. “They are avoiding accountability, open courts, and juries of their peers in favor of a closed and complicated bankruptcy court system. It’s time for common sense to prevail and for our leaders in the courts and in government to put a stop to this abuse.”

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.43
+1.08 (0.48%)
AAPL  270.97
-2.70 (-0.99%)
AMD  214.95
+1.52 (0.71%)
BAC  55.88
+0.61 (1.10%)
GOOG  311.33
+2.72 (0.88%)
META  661.50
+2.73 (0.41%)
MSFT  484.92
-1.00 (-0.21%)
NVDA  183.69
+2.70 (1.49%)
ORCL  198.38
+6.41 (3.34%)
TSLA  488.73
+7.53 (1.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.